Linda E. Chovan
Papers
1
Total Citations
38
H-Index
1
About
Dr. Linda E. Chovan is a pioneering figure in pharmaceutical bioanalysis, whose work has significantly advanced high-throughput drug discovery. Her primary research focus lies in the development of automated mass spectrometry methods for metabolic stability assays, a critical bottleneck in early-stage drug development. Her most influential contribution, the 2004 paper "Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays" (38 citations), introduced a transformative approach that automated LC/MS/MS method optimization. This innovation enabled laboratories to keep pace with high-throughput organic synthesis by rapidly screening drug candidates for metabolic stability, a key determinant of pharmacokinetic success. By replacing manual, time-consuming method development with an automated workflow, Chovan’s work directly accelerated the identification of viable drug leads, reducing preclinical timelines. Her contributions remain foundational in bioanalytical chemistry, cited by researchers seeking to improve efficiency in metabolic screening. Through this seminal work, Dr. Chovan has left a lasting impact on the integration of automation and mass spectrometry in drug discovery, helping to streamline the path from synthesis to clinical candidate selection.
Research Focus
Key Achievements
Top Papers
- 1